{"title":"Association between Coagulation Profile and Platelet Lymphocyte Ratio with Karnofsky Performance Status Scale In Brain Tumor Patients","authors":"Khansa Salsabila, P. P. Sinurat, I. Nasution","doi":"10.47353/jsocmed.v2i5.50","DOIUrl":null,"url":null,"abstract":"Introduction: Patients with tumor usually show abnormal laboratory coagulation tests, indicating a subclinical hypercoagulable state that contributes to morbidity and mortality. Hematologic markers such as the platelet-lymphocyte ratio (PLR) can be used as an index of tumor progression, high PLR is associated with morbidity and mortality in patients with primary or metastatic tumors. KPS is a method that is widely used to assess the functional status of a patient. The aim of this study is to determine the relationship between coagulation profile and platelet-lymphocyte with Karnofsky Performance Status Scale in Brain Tumor Patients.\nMethod: This study was an observational analytic study with a cross-sectional design using primary data sources taken consecutively from all brain tumor patients who were hospitalized in Inpatient Room at Haji Adam Malik General Hospital Medan who met the inclusion criteria. The parameters analyzed were Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), D dimer (DD), and PLR. Clinical outcome of brain tumor patients was assessed using KPS. To assess the relationship between coagulation marker factors and the ratio of platelets to lymphocytes to KPS, the Spearman and Gamma tests were used.\nResults: Of the 30 research subjects analyzed, the number of female subjects was comparable to that of males (50%). The highest age is in the age range of 61-70 years by 30%. The highest level of education was high school at 40%, the most research subjects were housewives at 33.3% and the most types of brain tumors were primary brain tumors at 56.7%. The highest KPS score during treatment was found in the <70 group of 76.7%. From the correlation test, it was found that there was a strong, significant relationship between the values of PT (p<0.02 r = -0.731), APTT (p<0.013 r = -0.761), D-dimer (p<0.001 r = -0.737) and PLR (p<0.001 r = 0.78) on the clinical outcome of brain tumor patients assessed by KPS.\nConclusion: There is a strong relationship between PT, APTT, D-dimer and PLR values on KPS in patients with brain tumor.","PeriodicalId":370087,"journal":{"name":"Journal of Society Medicine","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Society Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47353/jsocmed.v2i5.50","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Patients with tumor usually show abnormal laboratory coagulation tests, indicating a subclinical hypercoagulable state that contributes to morbidity and mortality. Hematologic markers such as the platelet-lymphocyte ratio (PLR) can be used as an index of tumor progression, high PLR is associated with morbidity and mortality in patients with primary or metastatic tumors. KPS is a method that is widely used to assess the functional status of a patient. The aim of this study is to determine the relationship between coagulation profile and platelet-lymphocyte with Karnofsky Performance Status Scale in Brain Tumor Patients.
Method: This study was an observational analytic study with a cross-sectional design using primary data sources taken consecutively from all brain tumor patients who were hospitalized in Inpatient Room at Haji Adam Malik General Hospital Medan who met the inclusion criteria. The parameters analyzed were Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), D dimer (DD), and PLR. Clinical outcome of brain tumor patients was assessed using KPS. To assess the relationship between coagulation marker factors and the ratio of platelets to lymphocytes to KPS, the Spearman and Gamma tests were used.
Results: Of the 30 research subjects analyzed, the number of female subjects was comparable to that of males (50%). The highest age is in the age range of 61-70 years by 30%. The highest level of education was high school at 40%, the most research subjects were housewives at 33.3% and the most types of brain tumors were primary brain tumors at 56.7%. The highest KPS score during treatment was found in the <70 group of 76.7%. From the correlation test, it was found that there was a strong, significant relationship between the values of PT (p<0.02 r = -0.731), APTT (p<0.013 r = -0.761), D-dimer (p<0.001 r = -0.737) and PLR (p<0.001 r = 0.78) on the clinical outcome of brain tumor patients assessed by KPS.
Conclusion: There is a strong relationship between PT, APTT, D-dimer and PLR values on KPS in patients with brain tumor.
导论:肿瘤患者通常显示实验室凝血检查异常,提示亚临床高凝状态,导致发病率和死亡率。血液学指标如血小板淋巴细胞比率(PLR)可作为肿瘤进展的指标,高PLR与原发性或转移性肿瘤患者的发病率和死亡率相关。KPS是一种广泛用于评估患者功能状态的方法。本研究的目的是利用Karnofsky性能状态量表确定脑肿瘤患者凝血状况与血小板淋巴细胞的关系。方法:本研究采用横断面设计的观察性分析研究,主要数据来源为棉兰Haji Adam Malik综合医院住院部所有符合纳入标准的脑肿瘤患者。分析参数为凝血酶原时间(PT)、活化部分凝血活素时间(aPTT)、D二聚体(DD)和PLR。采用KPS评价脑肿瘤患者的临床预后。为了评估凝血标志物因子与血小板/淋巴细胞/ KPS比值的关系,采用Spearman和Gamma试验。结果:在分析的30个研究对象中,女性受试者的数量与男性相当(50%)。年龄最高的是61-70岁,占30%。受教育程度最高的是高中(40%),研究对象最多的是家庭主妇(33.3%),脑肿瘤类型最多的是原发性脑肿瘤(56.7%)。治疗期间KPS评分以<70组最高,为76.7%。相关性检验发现,PT (p<0.02 r = -0.731)、APTT (p<0.013 r = -0.761)、d -二聚体(p<0.001 r = -0.737)、PLR (p<0.001 r = 0.78)值与KPS评价脑肿瘤患者的临床转归存在较强的显著相关性。结论:PT、APTT、d -二聚体和PLR值与脑肿瘤患者KPS有密切关系。